ABSI - NASDAQ

Absci Corporation

ABSI·NASDAQ

$5.94

-6.5%

HealthcareBiotechnology

Absci Corporation, a drug and target discovery company, provides biologic drug candidates and production cell lines using integrated drug creation platform for partners in the United States. Its integrated drug creation platform enables the creation of biologics by unifying the drug discovery and cell line development processes into one process. Absci Corporation was founded in 2011 and is headquartered in Vancouver, Washington.

Statements Value Model

At a Glance

Live Snapshot

Market Cap$926.08M

EPS-0.8400

P/E Ratio-7.07

Earnings Date08/11/2026

absi

Net Cash Provided by Financing Activities

Last Annual Value

105.95M

3-Year CAGR

172%

5-Year CAGR

10-Year CAGR

24%

Adjust for Inflation

Absci Corporation Competitors Analysis of Net Cash Provided by Financing Activities

ABSI · NASDAQ

Company	Net Cash Provided by Financing Activities	CAGR 3Y	CAGR 5Y	CAGR 10Y
Absci Corporation NASDAQ:ABSI	105.95M	N/A	-20.6%	N/A
REGENXBIO Inc. NASDAQ:RGNX	116.77M	N/A	-9.8%	99.1%
Corvus Pharmaceuticals, Inc. NASDAQ:CRVS	36.43M	66.8%	-10.1%	-6.5%
Prothena Corporation plc NASDAQ:PRTA	-139.00K	N/A	N/A	N/A
Gossamer Bio, Inc. NASDAQ:GOSS	6.42M	-67.7%	14.1%	66.2%
Verastem, Inc. NASDAQ:VSTM	263.31M	25.2%	107.3%	N/A
Ventyx Biosciences, Inc. NASDAQ:VTYX	122.11M	31.8%	-17.7%	N/A
MeiraGTx Holdings plc NASDAQ:MGTX	12.27M	-47.3%	48.3%	-5.1%
Erasca, Inc. NASDAQ:ERAS	1.10M	-5.4%	-69.8%	N/A
Olema Pharmaceuticals, Inc. NASDAQ:OLMA	211.30M	16.6%	173.1%	N/A

Absci Corporation Fair Value Envelope

ABSI · NASDAQ

Our analysis suggests that ABSI has a fair value of HIDDEN per share in the Base Case projection. With shares currently trading at $5.94, this represents a potential HIDDEN relative to our calculated worth for Absci Corporation.

HIDDEN

Intrinsic Value

Current Price: $5.94

Related Guides

Blog Categories

Continue your ABSI research with focused valuation guides.

Fundamentals

Decode statement quality and operating durability.

Accounting

Interpret line items with cleaner analytical framing.

Forecasting

Translate historical performance into forward scenarios.

Reference

Use practical frameworks for statement-led valuation.

Research Paths

Pick your next lens

Snapshot

Start with context, operating signals, and key market metrics.

Value Model

Stress test fair value across bear, base, and bull assumptions.

Statements

Validate revenue quality, margins, and balance sheet durability.

Earnings Call

Read management commentary and compare it with reported outcomes.

Dividends

Check payout sustainability and long-term distribution behavior.

Analyst Expectations

Review consensus spread and where estimate risk is concentrated.